Menu

Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia

J. BREZINOVA, A. BERKOVA, S. VCELIKOVA, Z. ZEMANOVA, S. IZAKOVA, I. SAROVA, H. CECHOVA, J. TAJTLOVA, L. GROSOVA, L. LIZCOVA, E. MALINOVA, M. ZEMANOVA, E. CMUNT, J. KARBAN, M. TRNENY, J. SCHWARZ, K. MICHALOVA

Abstract:

Telomere length was evaluated by terminal repeat fragment method in 66 previously untreated patients with B-chronic lymphocytic leukemia (B-CLL) to ascertain whether telomere shortening was associated with genomic aberrations, immunoglobulin variable heavy chain (IgVH) mutational status, CD38 and ZAP-70 expression, and telomerase activity. Chromosomal aberrations were present in peripheral blood cells of 73% patients (48/66), no difference in telomere length between patients with good and intermediate prognosis according to cytogenetics was found. Association between telomere length and IgVH mutational status, ZAP-70 and CD38 expression was proved as significantly shorter telomeres in patients with unmutated IgVH status (p=0.01) and ZAP-70 positivity (p=0.01) and CD38 positivity (p=0.05) were detected. Telomerase activity was positive in 11 patients out of 21 examined, correlation between telomere length and telomerase activity was found (p=0.05). Telomere length and telomerase activity in combination with other prognostic parameters complete the risk profile of B-CLL patients and might serve for an easy decision on optimal treatment strategy.

Issue: 3/2010

Volume: 2010

Pages: 215 — 221

DOI: 10.4149/neo_2010_03_215

Pubmed

Shopping cart is empty